Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 4601 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 4602 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 67 |
| 4603 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 47 |
| 4604 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 56 |
| 4605 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 4606 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 4607 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 4608 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 4609 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 4610 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 4611 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 4612 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Germany | 73 |
| 4613 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 4614 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 4615 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 70 |
| 4616 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 4617 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 4618 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 4619 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 4620 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 4621 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 4622 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2020 | Standard Therapy | Poland | 40 |
| 4623 | Apheresis | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 71 |
| 4624 | Apheresis | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 4625 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 65 |
| 4626 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 4627 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 4628 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 58 |
| 4629 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 4630 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 53 |
| 4631 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 4632 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 69 |
| 4633 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 62 |
| 4634 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 34 |
| 4635 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 42 |
| 4636 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 62 |
| 4637 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 56 |
| 4638 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 67 |
| 4639 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 68 |
| 4640 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 4641 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 64 |
| 4642 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 4643 | Apheresis | Allogeneic | Perforin Deficiency | Hematology | 2020 | Standard Therapy | Poland | 2 |
| 4644 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
| 4645 | Apheresis | Autologous | Primary Cerebral Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 4646 | Apheresis | Autologous | Primary Cerebral Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
| 4647 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 63 |
| 4648 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 4649 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 51 |
| 4650 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 66 |
| 4651 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 61 |
| 4652 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Germany | 54 |
| 4653 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Germany | 58 |
| 4654 | Apheresis | Allogeneic | Purine Nucleoside Phosphorylase Deficiency | Hematology | 2020 | Standard Therapy | Poland | 1 |
| 4655 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
| 4656 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 76 |
| 4657 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 57 |
| 4658 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 66 |
| 4659 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 56 |
| 4660 | Apheresis | Autologous | Secondary B-Cell Non-Hodgkin-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 73 |
| 4661 | Apheresis | Autologous | Secondary Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 54 |
| 4662 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 9 |
| 4663 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
| 4664 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
| 4665 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2020 | Standard Therapy | Poland | 2 |
| 4666 | Apheresis | Allogeneic | Sezary Syndrome | Hematology | 2020 | Standard Therapy | Poland | 44 |
| 4667 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
| 4668 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 57 |
| 4669 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 29 |
| 4670 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 64 |
| 4671 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 63 |
| 4672 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 29 |
| 4673 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 51 |
| 4674 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 60 |
| 4675 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
| 4676 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 74 |
| 4677 | Apheresis | Allogeneic | Β – Thalassemia | Hematology | 2020 | Standard Therapy | Poland | 6 |
| 4678 | Apheresis | Allogeneic | Β – Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 17 |
| 4679 | Adipose Tissue | Autologous | Alopecia | Dermatology | 2020 | Experimental Therapy | Poland | 68 |
| 4680 | Adipose Tissue | Autologous | Chondromalacia | Orthopedy | 2020 | Experimental Therapy | Poland | 45 |
| 4681 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 52 |
| 4682 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63 |
| 4683 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 41 |
| 4684 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 34 |
| 4685 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 48 |
| 4686 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 57 |
| 4687 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 59 |
| 4688 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 35 |
| 4689 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61 |
| 4690 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 56 |
| 4691 | Adipose Tissue | Autologous | Gonarthrosis; Shoulder Osteoarthritis | Orthopedy | 2020 | Experimental Therapy | Poland | 42 |
| 4692 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2020 | Experimental Therapy | Poland | 53 |
| 4693 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2020 | Experimental Therapy | Poland | 49 |
| 4694 | Adipose Tissue | Autologous | Omarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 70 |
| 4695 | Adipose Tissue | Autologous | Other Acquired Deformities Of The Ankle And Foot | Orthopedy | 2020 | Experimental Therapy | Poland | 41 |
| 4696 | Adipose Tissue | Autologous | Scar | Dermatology | 2020 | Clinical Trial | Poland | 0 |
| 4697 | Adipose Tissue | Autologous | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2020 | Experimental Therapy | Poland | 61 |
| 4698 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 5 |
| 4699 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 1 |
| 4700 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 6 |